Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00714636 · ClinicalTrials.gov registry record

Cerebrospinal Fluid Repository

A clinical trial of Amyotrophic Lateral Sclerosis and Motor Neuron Disease, sponsored by Drexel University College of Medicine.

Completed
Registry status
11
Enrollment target
1
Study location

NCT00714636 is a study of Amyotrophic Lateral Sclerosis and Motor Neuron Disease that has completed, run by Drexel University College of Medicine. The registered enrollment target is 11 participants, below the 898-participant average among 102 other Amyotrophic Lateral Sclerosis trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00714636, a study of Amyotrophic Lateral Sclerosis and Motor Neuron Disease, has completed, sponsored by Drexel University College of Medicine.

COMPLETED
Registry status
11 participants
Enrollment target
1
Study location

Study Summary

The purpose of a CSF repository is to collect samples of spinal fluid from controls and patients with neurologic disorders including but not exclusively ALS, Dementia, CRPS, neuropathies, and other neuromuscular diseases. This CSF repository will allow the use of CSF in biochemical studies of various neurologic diseases. It would also provide a supply of the necessary normal and disease control patients. CSF would be obtained from patients who are undergoing spinal taps for other reasons including diagnosis, treatment, or participation in clinical trials. We are proposing to collect an additional \< 3 ml of CSF from a lumbar puncture that is already being performed for diagnostic or therapeutic reasons, in order to store it in our laboratory for use in future research studies. No lumbar punctures will be initiated specifically for this protocol.

Study Locations (1)

Pennsylvania

  • MDA/ALS Center of Hope - Philadelphia

Trial Details

FieldValue
Enrollment Target 11 participants
Start Date 2006-10
Est. Completion 2008-10

What the Registry Record Tells You About NCT00714636

The ClinicalTrials.gov registry entry for NCT00714636 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 898-participant average among 102 other Amyotrophic Lateral Sclerosis trials with a reported enrollment target (99% lower). The listed sponsor is Drexel University College of Medicine, which has 25 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Amyotrophic Lateral Sclerosis appearing as the primary indexed condition, and to 0 interventions.

NCT00714636 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT00714636 about?

NCT00714636 is a clinical study titled "Cerebrospinal Fluid Repository". The purpose of a CSF repository is to collect samples of spinal fluid from controls and patients with neurologic disorders including but not exclusively ALS, Dementia, CRPS, neuropathies, and other neuromuscular diseases. This CSF repository will allow the use of CSF in biochemical studies of variou...

What is the current status of trial NCT00714636?

This trial is currently completed. The enrollment target is 11 participants. The study started on 2006-10. Estimated completion is 2008-10.

What conditions does trial NCT00714636 study?

This clinical trial studies the following conditions: Amyotrophic Lateral Sclerosis, Motor Neuron Disease, Neurodegenerative Disease, Cerebrospinal Fluid.

Who is sponsoring clinical trial NCT00714636?

This trial is sponsored by Drexel University College of Medicine, which has 25 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00714636 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Amyotrophic Lateral Sclerosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.